Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:43 pm Purchase | 13G | MOLECULIN BIOTECH INC MBRX | ARMISTICE CAPITAL LLC | 3,316,221 9.99% | 3,316,221 (New Position) | View |
| 2021-02-10 11:28 am Sale | 13G | MOLECULIN BIOTECH INC MBRX | VANGUARD GROUP INC | 591,954 0.95% | -2,010,160 (-77.25%) | View |
| 2021-01-20 11:14 am Sale | 13G | MOLECULIN BIOTECH INC MBRX | Empery Asset Management LP | 2,990,053 4.57% | -759,947 (-20.27%) | View |
| 2021-01-04 2:02 pm Sale | 13G | MOLECULIN BIOTECH INC MBRX | SABBY MANAGEMENT LLC | 3,116,982 11% | -633,018 (-16.88%) | View |
| 2020-11-13 06:01 am Purchase | 13G | MOLECULIN BIOTECH INC MBRX | Lincoln Park Capital Fund LLC | 4,787,254 7.52% | 4,787,254 (New Position) | View |
| 2020-02-11 4:40 pm Purchase | 13G | MOLECULIN BIOTECH INC MBRX | VANGUARD GROUP INC | 2,602,114 5.69% | 2,602,114 (New Position) | View |
| 2020-02-11 2:16 pm Purchase | 13G | MOLECULIN BIOTECH INC MBRX | Empery Asset Management LP | 3,750,000 7.05% | 3,750,000 (New Position) | View |
| 2020-02-10 3:17 pm Sale | 13G | MOLECULIN BIOTECH INC MBRX | CVI Investments Inc. | 1,800,000 3.8% | -1,325,000 (-42.40%) | View |
| 2020-02-07 1:36 pm Purchase | 13G | MOLECULIN BIOTECH INC MBRX | SABBY MANAGEMENT LLC | 3,750,000 11% | 1,468,188 (+64.34%) | View |
| 2020-01-07 6:54 pm Sale | 13G | MOLECULIN BIOTECH INC MBRX | SABBY MANAGEMENT LLC | 2,281,812 11% | -843,188 (-26.98%) | View |
| 2019-05-02 11:47 am Purchase | 13G | MOLECULIN BIOTECH INC MBRX | CVI Investments Inc. | 3,125,000 7.1% | 3,125,000 (New Position) | View |
| 2019-04-23 1:30 pm Purchase | 13G | MOLECULIN BIOTECH INC MBRX | SABBY MANAGEMENT LLC | 3,125,000 11% | 2,373,825 (+316.01%) | View |